Skip to main content
NeuronFeed

Innovaccer vs Truveta

Which Healthcare AI tool is better in 2026?

Innovaccer

$675M

Truveta

$515M

Side-by-side

Verdict

Innovaccer is the more established option (raised $675M); pricing is comparable on both sides.

Metric Innovaccer Truveta
Taglinei
Foundedi 2020🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 76🏆 75
Total fundingi $675M🏆 $515M
Latest roundi Series F · Jan 2025 Series C · Jan 2025
Valuationi $3.5B🏆 $1B
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for Innovaccer and Truveta.

Capability Innovaccer Truveta
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of Innovaccer

  • Has raised more capital ($675M vs $515M)
  • Higher Neuron score (76 vs 75)

🔵 Strengths of Truveta

  • Newer company (2020)

Which should you choose?

Choose Truveta if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Innovaccer if you want the most established option — it has raised $675M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

Innovaccer vs Truveta — which is better?

It depends on your priority. Innovaccer has raised more capital and is the more established option; Truveta has broader feature depth. See the side-by-side table above.

Is Innovaccer cheaper than Truveta?

No — Truveta's cheapest paid plan is Free, while Innovaccer's is Free.

Do Innovaccer and Truveta offer free plans?

Innovaccer: Yes, has a free plan. Truveta: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.